Search PubMed⌕ Search

Biomedical subjects

L R Chervu

Publications and source records attributed to L R Chervu.

33 records · Page 2Linked to original sources

Thyroid uptake measurements with I-123: problems and pitfalls: concise communication.

The measurement of radioiodine uptake is generally considered to be straight-forward and accurate. However, during the past two decades, discrepancies in "normal" thyroid uptake values have been noticed between Montefiore Hospital and Medical Center and the Hospital of Albert Einstein College of Medicine. These differences were attributed to differences in patient population. Further investigation revealed that the persisting uptake discrepancies arose from neck-phantom differences and variations in procedure. Differences in presumably standardized neck-phantom attenuation characteristics have been shown to cause large variations in count rates from I-123 and I-131 standard capsules. The effect of high-voltage fluctuation on phantom count rates is more pronounced with I-123 than with I-131. In constant levels of high-energy contaminants in I-123 also affect the uptake measurements. large errors in the measurements of thyroid uptake values may result from seemingly unimportant variations in technique. A stable high-voltage power supply, precise high-voltage adjustment, careful selection of energy window, and the use of a standardized neck phantom with generally accepted attenuation characteristics are absolutely essential if RAIU values are to be compared and appropriate therapeutic doses are to be administered based on these measurements.

Humans↗

Static testicular imaging utilizing 201Tl.

Successful testicular imaging of rat and rabbit testes was achieved utilizing the radiopharmaceutical Thallium-201. These observations indicate the usefulness of Thallium-201 as an agent for testicular imaging and suggest a clinical application in localizing the impalpable testis in humans.

Animals↗

Use of 99mTc-Cu-DTPA complex as a renal function agent.

The use of cuprous ion as a reducing agent for pertechnetate is described for the first time. The potential usefulness of a 99mTc-Cu-DTPA complex as a renal function agent was evaluated by organ distribution studies in animals and by simultaneous continuous-infusion and single-injection clearance studies. Radioiodinated iothalamate was used as a standard for the measurement of GFR. The ratio for the clearance with the new copper complex to that with iothalamate is close to unity, both for continuous infusion (0.97 +/- 0.01 s.e) and for single injection (1.05 +/- 0.03). The coefficients of correlation are similarly close to unity: 0.96 and 0.99, respectively. Dialysis of plasma samples obtained after injection of 99mTc-Cu-DTPA into bilaterally nephrectomized rats indicates that only small amounts (less than 4%) of the complex are protein-bound. These data and the low toxicity of the copper preparation in animals appear to justify its investigation for kidney function measurement and imaging in man as well as its use as a GFR agent in animal studies.

Animals↗

Radiolabeling of antigens: procedures and assessment of properties.

The role of labeled tracers in radioimmunoassay procedures (RIA) and the advantages of the iodine-labeled antigens over 14C or tritium-labeled antigens are discussed. Different methods of labeling with iodine isotopes are presented. The ease with which microgram amounts of hormonal proteins are tagged, achieving high specific activity with the chloramine-T procedure of Hunter and Greenwood, is indicated in a detailed presentation of a typical procedure. More sophisticated methods that present none of the drawbacks of the chemical oxidation methods for iodination would seem to have greater versatility, resulting in labeled antigens with better immunologic properties. These are likely to come into vogue for many inhouse preparations of labeled antigens in the next few years. The iodination procedures developed for haptenic substances have extended the usefulness of the RIA method to many steroidal hormones and have helped to achieve a limit of detectability at picogram levels. Greater specificity has also resulted. The assessment of the properties of the labeled antigens is equally important, and methods to evaluate the parameters of purity, immunoreactivity, specific activity as well as storage, are discussed. This review is intended to serve as an introduction to the radiolabeling of antigens or haptens. A thorough appreciation of the problems and pitfalls in these procedures is essential for the development of a new RIA or adaptation of a well-studied method for routine use.

Angiotensin II↗

Protein-losing enteropathy detected by 99mTc-labeled human serum albumin abdominal scintigraphy.

99mTc-labeled human serum albumin (HSA) abdominal imaging is a new way of demonstrating gastrointestinal protein loss. We present two children with hypoalbuminemia of obscure etiology in whom albumin loss was localized in the gastrointestinal tract with 99mTc-HSA scintigraphy and the loss correlated with abnormal fecal alpha 1-antitrypsin excretion. In the absence of gastrointestinal blood loss or contamination of the 99mTc-HSA with free pertechnetate, significant activity accumulating in the gastrointestinal tract and moving with its contents is thought to represent 99mTc-HSA leakage into bowel lumen. Abdominal imaging with 99mTc-HSA has a low radiation burden to the patient and is readily available, relatively inexpensive, and easily performed. It can be used as a screening test for the detection of protein-losing enteropathy. It also offers the potential of being able to localize the site of protein loss visually within the gastrointestinal tract.

Child↗